OPEN PHACTS FOUNDATION LBG

Their core work

The Open PHACTS Foundation is a Cambridge-based SME that builds and maintains open data infrastructure for drug discovery and life sciences research. They specialize in integrating large-scale pharmacological, chemical, and biological datasets so that researchers and companies can query multiple sources through unified platforms. Their work spans from big data integration architectures to FAIR data standards implementation, with a strong focus on making toxicology and pharmaceutical data findable, accessible, interoperable, and reusable.

What they specialise in

How they've shifted over time

Their trajectory shows a clear arc from general-purpose big data infrastructure (BigDataEurope, 2015) toward increasingly specialized life science data management. By 2016 they were contributing to computational toxicology data needs in EU-ToxRisk, and by 2019 they had moved fully into FAIR data standardization with FAIRplus — their best-funded project. The shift from "big data integration" to "FAIRification" reflects the broader life sciences trend toward structured, standards-compliant data sharing.

Moving toward FAIR data maturity assessment and standardization services for pharmaceutical and life science organizations — a growing need as EU funding increasingly mandates FAIR compliance.

How they like to work

Open PHACTS Foundation operates exclusively as a participant, never coordinating projects — consistent with their role as a specialist data infrastructure provider that plugs into larger research efforts. They work in large consortia (75 unique partners across just 3 projects), suggesting they thrive in flagship-scale initiatives where their data integration expertise serves many partners. This makes them easy to work with: they bring a focused technical contribution without competing for project leadership.

Despite only 3 projects, they have built connections with 75 unique partners across 16 countries — a remarkably wide network driven by participation in large flagship consortia like EU-ToxRisk. Their reach is thoroughly pan-European with no obvious geographic concentration.

What sets them apart

Open PHACTS Foundation sits at the intersection of data engineering and life sciences — they are not a research lab producing new science, but a foundation that makes existing scientific data usable and interoperable. This is a rare niche: most partners in pharma/toxicology consortia are either universities generating data or companies consuming it, while Open PHACTS provides the connective tissue. For consortium builders needing a partner to handle data integration, FAIR compliance, or cross-database interoperability in health and pharma projects, they are a natural fit.

Highlights from their portfolio

• FAIRplus
  Their largest-funded project (EUR 211,938), focused on FAIR data maturity — directly aligned with growing EU mandates for open science compliance.
• EU-ToxRisk
  A major European flagship program in mechanism-based toxicology with a long duration (2016-2021), connecting Open PHACTS to the regulatory toxicology community.